Gym Equipment Injury Case Study: Product Liability, Shoulder Tear, and Pharmacy Lien

James Wong — Founder & Pharmacist, LienScripts | February 13, 2026 | 9 min read

A 38-year-old man is thrown from a malfunctioning commercial treadmill at a gym, tearing his rotator cuff and separating his AC joint. His health insurance denied all injury-related care under a third-party liability exclusion. A pharmacy lien covered the full 12-month surgical and PT recovery arc — and the MERIT supported a product liability demand against the treadmill manufacturer.

Case Background

Note: This is a fictionalized case study based on composite facts. Names and identifying details are not real. The clinical details represent typical medication patterns for this injury type.

The Client: Nathan C., 38, a project manager at a tech company in the Austin, Texas area. Active, athletic, and a regular gym member for over a decade. Nathan worked out four days per week and ran on the gym's commercial treadmills regularly.

The Incident: On a Tuesday morning, Nathan was running at a moderate pace on a commercial treadmill at his gym. Without warning, the treadmill's belt decelerated abruptly — dropping from approximately 7.5 mph to near-zero in under one second. Nathan was thrown forward, striking the front of the machine with his right arm outstretched to brace himself, and then fell and rolled onto the gym floor.

Witnesses at the gym confirmed that the machine had been producing unusual mechanical sounds in the days before the incident. The gym's maintenance log — obtained in discovery — showed the machine had been flagged twice in the preceding month for "belt sensor error" warnings but had never been taken out of service or serviced.

The Legal Structure:

Nathan's personal injury attorney pursued two parallel theories:

  1. Product liability against the treadmill manufacturer — the belt deceleration event was caused by a defective speed sensor and firmware control module that failed to implement a safe deceleration protocol, instead executing a near-instantaneous stop. Engineering analysis confirmed the defect was present in multiple units of the same model.

  2. Premises liability / negligence against the gym — the gym's failure to take the flagged machine out of service after two documented sensor warning events constituted negligent maintenance and a foreseeable hazard to members.

Nathan had health insurance through his employer's group plan. The carrier invoked a third-party liability exclusion within the first three weeks, denying all injury-related medical and pharmacy claims pending resolution of the legal matter. LienScripts was enrolled by referral from Nathan's orthopedic surgeon's office.


Injuries Sustained

Emergency evaluation and subsequent MRI confirmed:

  • Full-thickness rotator cuff tear — supraspinatus, with partial involvement of the infraspinatus (right shoulder)
  • Acromioclavicular (AC) joint separation — Grade II (partial ligament tear, no surgical reduction required independently, but relevant to overall shoulder stability post-repair)
  • Anterior labral fraying — partial, noted on MRI but not requiring surgical intervention
  • Right elbow contusion — impact injury from striking the treadmill housing; soft tissue only
  • Cervical strain — from the whiplash mechanism during the fall

The full-thickness rotator cuff tear with AC joint involvement was the primary injury. Nathan's orthopedic shoulder specialist made clear at the initial consultation: without surgical repair, Nathan would face a progressive decline in shoulder function and a very high likelihood of needing surgery in any case — but with worse baseline tissue quality. Surgery was recommended within six to eight weeks.

[!KEY] Full-thickness rotator cuff tears from acute traumatic events — as opposed to degenerative tears — typically require surgical repair in active patients under 60. The product liability framework here is important: the defective treadmill caused a specific, discrete mechanical event that produced an acute structural injury. This is different from a gradual-onset sports injury and directly supports a causation narrative against the manufacturer.


Pre-Surgical Phase (Months 1–2)

The six to eight week pre-surgical period allowed time for the cervical strain to stabilize and for pre-operative clearance workup. During this period, Nathan's treating physicians focused on pain management and inflammation control.

Medications enrolled on pharmacy lien:

Medication Indication Notes
Meloxicam 15 mg Shoulder and cervical inflammation Once daily
Omeprazole 20 mg GI protection for NSAID use Co-prescribed
Cyclobenzaprine 10 mg at bedtime Cervical and shoulder muscle spasm Nighttime dosing for sleep; tapered at week 6
Tramadol HCl 50 mg Breakthrough pain during ADL As-needed; discontinued pre-op
Topical diclofenac gel 1% AC joint and anterior shoulder pain Applied to anterior shoulder region

Nathan's health insurance had denied all of these as injury-related under the third-party exclusion. All five were enrolled in LienScripts from week one, at $0 out-of-pocket to Nathan.

Physical therapy was not initiated in the pre-surgical phase — the orthopedic surgeon advised against aggressive shoulder mobilization prior to repair. Nathan underwent pre-operative strengthening of uninvolved muscle groups only.


Surgical Phase: Rotator Cuff Repair (Month 2)

Nathan underwent arthroscopic rotator cuff repair at month two. The procedure involved:

  • Supraspinatus repair with anchor fixation (full-thickness tear repair)
  • Infraspinatus partial repair — the partial involvement was addressed during the same procedure
  • AC joint assessment — the grade II separation was assessed arthroscopically; the joint capsule was found stable enough to manage conservatively with post-operative physical therapy rather than surgical stabilization
  • Anterior labrum debridement — the partial labral fraying was debrided during the procedure

The procedure was performed at an outpatient surgery center and Nathan was discharged the same day in an immobilization sling.

Post-operative medications enrolled on pharmacy lien:

Medication Indication Notes
Oxycodone/acetaminophen 5/325 mg Acute post-surgical pain Weeks 1–3 post-op; strict taper schedule
Celecoxib 200 mg Post-surgical inflammation Weeks 2–8 post-op
Omeprazole 20 mg (continued) GI protection Continued
Ondansetron 4 mg Post-anesthesia nausea First 5 days post-op
Diazepam 5 mg at bedtime Shoulder muscle guarding, sleep disruption Weeks 1–4 post-op; strictly limited course
Gabapentin 300 mg TID Post-surgical neuropathic pain; shoulder and arm Added week 3; titrated and maintained through month 8

The diazepam course — prescribed specifically for the intense shoulder muscle guarding and sleep disruption common in the immediate post-op period — was tightly limited to four weeks. Nathan's surgeon and pharmacist coordinated to ensure a clear taper schedule and no refills.

Gabapentin was added at week three when Nathan reported persistent burning pain down his right arm — a neuropathic pattern consistent with post-surgical nerve irritation in the suprascapular nerve distribution. This was a recognized complication of the surgical approach and was managed with gabapentin through month eight, when the neuropathic component resolved.


Physical Therapy and Recovery Phase (Months 3–10)

Post-operative shoulder rehabilitation from rotator cuff repair is among the longest PT arcs in orthopedic care — typically 9 to 12 months from surgery to return to full activity. Nathan's PT protocol followed the standard phased approach:

  • Phase 1 (months 3–5): Passive range-of-motion, pendulum exercises, gradual active-assisted movement. Sling discontinued at week 8.
  • Phase 2 (months 5–8): Active range-of-motion, early rotator cuff strengthening, scapular stabilization.
  • Phase 3 (months 8–10): Progressive resistance, sport-specific training, return-to-activity clearance.

Medications during PT and recovery:

Medication Indication Duration
Celecoxib 200 mg (continuing) Ongoing periarticular inflammation Through month 6
Gabapentin 300 mg TID (continuing) Neuropathic arm pain Through month 8
Topical diclofenac gel 1% Anterior shoulder soreness during PT exercises Months 3–10
Meloxicam 15 mg (re-initiated month 7) Flare of AC joint pain during Phase 2 strengthening Months 7–9
Lidocaine 5% topical patch Focal suprascapular nerve pain during Phase 3 Months 9–10

At month seven, during the intensive Phase 2 strengthening exercises, Nathan experienced a flare of AC joint pain — the grade II separation, though managed conservatively, created persistent AC joint sensitivity during overhead and cross-body loading exercises. His surgeon briefly re-initiated meloxicam for a two-month course to manage this inflammatory flare. This re-initiation was documented in the pharmacy record, showing treatment escalation in direct response to a specific clinical finding during rehabilitation.

[!KEY] Rotator cuff repair recovery is not a straight line. Medication needs escalate and de-escalate across multiple phases, with new clinical findings — like the AC joint flare or the neuropathic arm pain — generating new prescriptions. A comprehensive pharmacy lien that covers the full 10-month recovery arc, with all of these clinical events documented in the MERIT, presents a far stronger damages picture than a fragmented billing record from multiple pharmacies.

At month ten, Nathan received final functional clearance from his orthopedic surgeon. He had achieved 90% of pre-injury strength and full range of motion. The surgeon noted residual AC joint sensitivity was expected to persist at a low level long-term.


Final Documentation Phase (Months 10–12)

The pharmacy lien continued through month twelve as Nathan's attorney finalized the product liability and premises liability demand packages.

Additional medications during close-out:

Medication Indication Notes
Topical diclofenac gel 1% (continuing PRN) Residual activity-related shoulder pain Monthly supply; continued long-term
Duloxetine 30 mg Added month 11 for persistent neuropathic shoulder and arm pain; also addressed occupational stress related to injury impact on work performance Months 11–12+

Nathan's pain management physician added duloxetine at month eleven for persistent neuropathic pain that had not fully resolved despite gabapentin discontinuation. Additionally, Nathan had experienced significant occupational impact — his work as a project manager required extended periods at a keyboard, and residual shoulder pain had reduced his work productivity for nearly a year. Duloxetine addressed both the neuropathic component and the occupational stress dimension.


The Product Liability Demand and MERIT Role

Nathan's attorney prepared separate demand packages targeting the treadmill manufacturer and the gym.

Against the manufacturer:

The engineering analysis confirmed the treadmill's speed control firmware lacked a mandated gradual deceleration safety protocol required under applicable ASTM standards for commercial fitness equipment. The defect was present across the manufacturer's model line. The manufacturer had received prior notice of similar incidents involving the same model.

The MERIT from LienScripts provided:

  1. A 12-month medication timeline confirming continuous injury-related treatment from the day of the incident through the demand date
  2. Phase-specific medication documentation — pre-surgical, post-surgical, and PT phases were clearly distinguishable from the prescription record, matching the surgical and therapy records
  3. Escalation documentation — the re-initiation of meloxicam at month seven for the AC joint flare, and the addition of duloxetine at month eleven, showed ongoing clinical management well beyond the initial surgical recovery
  4. Neuropathic complication record — gabapentin from week three through month eight established a documented post-surgical complication with a clear pharmaceutical management arc
  5. The pharmacy lien balance as economic damages — representing the full medication burden created by the manufacturer's defective product

Against the gym:

The premises liability theory rested on the maintenance log showing two prior sensor warning events without remediation. The MERIT complemented this argument by demonstrating that Nathan's injuries were clinically serious enough to require sustained pharmaceutical management — not a brief, self-limiting incident that might be characterized as de minimis.

[!KEY] In product liability cases involving fitness equipment, the MERIT serves as a clinical timeline that connects the defective product event directly to months of documented medication management. It bridges the gap between the engineering expert's opinion (this machine was defective) and the damages expert's calculation (this defect caused this specific medical burden). Every prescription in the MERIT is a data point supporting that connection.


Settlement Outcome

The case settled jointly with the treadmill manufacturer's product liability carrier and the gym's general liability carrier at month twelve. The settlement addressed:

  • Orthopedic medical expenses (surgeon fees, surgery center, post-op visits)
  • Physical therapy (10-month course)
  • The pharmacy lien balance with LienScripts — paid in full at closing
  • Lost productivity / occupational impact (Nathan documented reduced performance reviews and missed promotion consideration during the injury period)
  • Non-economic damages: pain and functional limitation during 12 months of treatment and recovery, and permanent residual AC joint sensitivity
  • Future medical expenses: the orthopedic surgeon's opinion on potential AC joint intervention and long-term anti-inflammatory needs was incorporated

Nathan's net recovery after all liens, fees, and costs represented meaningful compensation for the disruption to his professional and personal life caused by the defective treadmill.


Key Takeaways

  1. Commercial gym equipment product liability cases are viable when defects are documented. Treadmill belt deceleration failures, sensor malfunctions, and firmware control defects are mechanical failures that can be traced to specific product defects — especially when the manufacturer had prior notice of similar incidents.

  2. Gym negligence and product liability can be pursued simultaneously. The gym's failure to take a flagged machine out of service creates independent premises liability exposure that complements the product liability claim against the manufacturer.

  3. Rotator cuff repair generates a 10-to-12-month medication arc. Pre-op anti-inflammatories, post-op opioid taper, COX-2 inhibitors, gabapentin for neuropathic complications, and topical agents across the PT phases are all predictable and documentable. A pharmacy lien that covers the full arc produces a far stronger MERIT than piecemeal pharmacy records.

  4. The MERIT in a product liability case is a clinical timeline that connects defective product to specific medical damages. Plaintiff attorneys should treat the pharmacy record as an exhibit in the causation and damages case, not just a line item in the medical expenses column.


Related Resources

Frequently Asked Questions

Can I sue a gym for a treadmill injury?

Yes, potentially on two theories: product liability against the equipment manufacturer if the injury was caused by a product defect (like a defective speed sensor or firmware failure), and premises liability against the gym if the gym failed to maintain or remove a machine it knew or should have known was unsafe. Many gym injury cases pursue both theories simultaneously. A pharmacy lien allows you to cover all injury-related medications at $0 out-of-pocket while the legal case proceeds.

What medications are typically needed after rotator cuff repair surgery?

Rotator cuff repair typically involves a short opioid taper (2–3 weeks) for acute post-surgical pain, a COX-2 inhibitor or NSAID for inflammation management across the first 6–8 weeks, an antiemetic for post-anesthesia nausea, and often a muscle relaxant for guarding in the immediate post-op period. If neuropathic pain develops — which is common when the surgical approach involves nerve-adjacent dissection — gabapentin may be added. Topical analgesics are frequently used during the physical therapy phase to support range-of-motion exercises.

How does a pharmacy lien work when health insurance denies injury-related medications?

When a health insurance carrier invokes a third-party liability exclusion — denying all injury-related care because a legal claim is pending — a pharmacy lien allows the injured patient to fill all prescribed medications at $0 out-of-pocket through the PI process. The pharmacy lien balance accumulates and is paid from PI settlement proceeds at the close of the case. The patient never pays out-of-pocket, and the lien is resolved from the recovery against the negligent party.

What is the MERIT and how does it help in a product liability case?

The MERIT (Medication Evaluation & Rationale for Injury Treatment) is a comprehensive, chronologically-organized document from LienScripts that records every medication fill across the full treatment arc — dates, medications, doses, quantities, days supply, and prescribing physicians. In a product liability case, the MERIT provides a clinical timeline linking the defective product event to months of documented pharmaceutical management, supporting causation opinions from treating physicians and establishing the pharmacy lien balance as a concrete economic damages figure caused by the defendant's defective product.